Pmlive.com, the Surrey-based go-to resource for pharmaceutical industry news, published an article detailing Beyond’s recommendations for pharma companies in regards to the new Facebook regulations implemented on 15 August. As explained in a recent post, Facebook opted to prevent healthcare company pages from disabling comments, sparking a reluctance on pharma companies’ behalf to delve into the social media platform because of potential problems including posts providing misleading product information, promoting off-label use or reports of adverse effects of drugs.
The piece, penned by Beyond’s head of analytics Nils Mork-Ulnes, advocates for a customisable, scalable moderating application, much in line with our own PharModerator app. With the aid of easily malleable tools and more concrete FDA guidelines, the piece concludes, pharma companies should be able to traverse the digital realm with confidence and ease.
Read the article here.